Ondansetron Pharmacenter

Ondansetron, the active ingredient in Ondansetron Pharmacenter, is a serotonin 5-HT3 receptor antagonist presented as a strength/form for oral use. It helps prevent nausea and vomiting caused by chemotherapy, radiation therapy, and surgery in adult and pediatric patients. GNH USA supplies Ondansetron Pharmacenter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Ondansetron Pharmacenter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Ondansetron is used to manage nausea and vomiting associated with several therapeutic pathways. - Chemotherapy-induced nausea and vomiting: Reduces the frequency and severity of acute and delayed episodes. - Radiation-induced nausea and vomiting: Helps control nausea during and after radiotherapy. - Post‑operative nausea and vomiting: Decreases the incidence of nausea and vomiting after surgical procedures.

Common Side Effects: - Headache: mild to moderate headache reported in clinical use. - Constipation: occasional reduced bowel movements. - Diarrhoea: loose stools may occur. - Fatigue: feeling of tiredness or low energy. - Dizziness: transient light‑headedness.

Serious or Rare Side Effects: - Cardiac arrhythmia: QT‑interval prolongation leading to irregular heart rhythm. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Serotonin syndrome: rare but serious condition when combined with other serotonergic agents. - Hepatic dysfunction: elevated liver enzymes indicating liver stress. - Vision changes: blurred vision or other visual disturbances.

Before prescribing Ondansetron, consider the following precautions: - Cardiac assessment: evaluate baseline ECG in patients with known cardiac disease. - Electrolyte balance: correct hypokalemia or hypomagnesemia which can predispose to QT prolongation. - Drug interactions: review concomitant medications that affect QT interval. - Pregnancy: use only if clearly needed; weigh potential benefits against risks. - Lactation: assess risk versus benefit for nursing mothers. - Store at below 25°C: keep in the original container, protect from moisture and light.

Ondansetron may interact with several medication classes.

Major Interactions (Avoid): - Anti‑arrhythmic drugs (e.g., amiodarone, quinidine): increase risk of QT prolongation. - Certain antibiotics (e.g., erythromycin, clarithromycin): may enhance QT prolongation. - Antifungal agents (e.g., fluconazole, itraconazole): potentiate QT effects.

Moderate Interactions (Monitor Closely): - Opioids (e.g., morphine and hydromorphone ) : may increase serotonin levels and risk of serotonin syndrome. - Tricyclic antidepressants : potential for additive cardiac effects . - Dexam t t t